{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:31:51Z","timestamp":1791304311085,"version":"4.3.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11894-016-0535-8","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T23:43:09Z","timestamp":1476661389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Acute-on-chronic Liver Failure"],"prefix":"10.1007","volume":"18","author":[{"given":"Shiv Kumar","family":"Sarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"key":"535_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","volume":"8","author":"S Sarin","year":"2014","unstructured":"Sarin S, Chandan K, Zaigham A, for APASL ACLF working partyl, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2014;8:453\u201371. This is the consensus statement of APASL on ACLF. It provides the definition, concept and management of ACLF patients.","journal-title":"Hepatol Int"},{"key":"535_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2013.02.010","volume":"59","author":"W Bernal","year":"2013","unstructured":"Bernal W, O\u2019Grady JG, Wendon J, Williams R. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74\u201380.","journal-title":"J Hepatol"},{"key":"535_CR3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426\u201337. This study forms the main cohort on the basis of which the EASL CLIF derived the western ACLF definition. It defined the organ failure and outcomes.","journal-title":"Gastroenterology"},{"key":"535_CR4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/lt.24329","volume":"21","author":"JG O\u2019Leary","year":"2015","unstructured":"O\u2019Leary JG, Orloff SL, Levitsky J, Martin P, Foley DP. Keeping high model for end-stage liver disease score liver transplantation candidates alive. Liver Transpl. 2015;21:1428\u201337.","journal-title":"Liver Transpl"},{"issue":"3","key":"535_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","volume":"13","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Nat Rev Gastroenterol Hepatol. 2016;13(3):131\u201349. A recently pubished review article that describes in detail the mechanism of ACLF and management plans.","journal-title":"Nat Rev Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"535_CR6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","volume":"62","author":"R Jalan","year":"2015","unstructured":"Jalan R, Pavesi M, Wendon J, Bernardi M, Arroyo V, CANONIC Study Investigators; EASLCLIF Consortium, et al. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol. 2015;62(4):831\u201340.","journal-title":"J Hepatol"},{"key":"535_CR7","unstructured":"Choudhury AK, \u2026 Sarin SK, et al. for APASL ACLF working party. Systemic Inflammatory Response Syndrome (SIRS) - a potential clinical marker for early sepsis and survival in Acute-on-chronic liver failure (ACLF). Hepatology 2014;60(4):(suppl). AASLD abstracts."},{"key":"535_CR8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1053\/j.gastro.2013.04.024","volume":"144","author":"JS Bajaj","year":"2013","unstructured":"Bajaj JS. Defining acute-on-chronic liver failure: will East and West ever meet? Gastroenterology. 2013;144:1337\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"535_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.dld.2011.08.029","volume":"44","author":"H Garg","year":"2012","unstructured":"Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis. 2012;44(2):166\u201371.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"535_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/egh.11.47","volume":"5","author":"W Laleman","year":"2011","unstructured":"Laleman W, Verbeke L, Meersseman P, Wauters J, Cassiman D, et al. Acute-on-chronic liver failure: current concepts on definition pathogenesis, clinical manifestations and potential therapeutic interventions. Exp Rev Gastroenterol Hepatol. 2011;5(4):523\u201337.","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"535_CR11","unstructured":"Choudhury AK, \u2026 Sarin SK, for APASL ACLF Working party. AARC-ACLF Score predicts 30 day survival better than CLIFSOFA and MELD scores in patients with ACLF. Hepatol Int. 2016;10(Suppl 1):S3"},{"key":"535_CR12","doi-asserted-by":"crossref","unstructured":"Choudhury AK, \u2026 Sarin SK, for APASL ACLF Working party. The decision for liver transplant in acute-on-chronic liver failure (ACLF) - first week is the crucial period - analysis of the APASL ACLF Research Consortium (AARC) prospective data of 1021 patients. J Hepatol. 2016;64:S151.","DOI":"10.1016\/S0168-8278(16)00046-5"},{"key":"535_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jceh.2013.11.003","volume":"3","author":"KK Singh","year":"2013","unstructured":"Singh KK, Panda SK, Shalimar, Acharya SK. Patients with diabetes mellitus are prone to develop severe hepatitis and liver failure due to hepatitis virus infection. J Clin Exp Hepatol. 2013;3:275\u201380.","journal-title":"J Clin Exp Hepatol"},{"key":"535_CR14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","volume":"46","author":"SK Acharya","year":"2007","unstructured":"Acharya SK, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46:387\u201394.","journal-title":"J Hepatol"},{"key":"535_CR15","doi-asserted-by":"crossref","unstructured":"Goel A, \u2026 Sarin SK; for APASL ACLF Working party. Better survival in patients with hepatitis E virus compared to other acute insults causing Aute-on-Chronic Liver Failure (ACLF) \u2013 from APASL-ACLF research consortium (AARC) data. J Hepatol. 2016;64:S355.","DOI":"10.1016\/S0168-8278(16)00520-1"},{"key":"535_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27990","author":"IM Sayed","year":"2015","unstructured":"Sayed IM, Vercouter AS, Abdelwahab SF, et al. Is HEV an emerging problem in industrialized countries? Hepatology. 2015. doi: 10.1002\/hep.27990 .","journal-title":"Hepatology"},{"issue":"6","key":"535_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1440-1746.2007.05243.x","volume":"23","author":"M Kumar","year":"2008","unstructured":"Kumar M, Sharma BC, Sarin SK. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus related chronic liver disease. J Gastroenterol Hepatol. 2008;23(6):83\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"535_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjmed.2005.07.013","volume":"118","author":"EB Keeffe","year":"2005","unstructured":"Keeffe EB. Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med. 2005;118:21\u20137.","journal-title":"Am J Med"},{"key":"535_CR19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12072-010-9204-4","volume":"4","author":"X Zhang","year":"2010","unstructured":"Zhang X, Ke W, Xie J, Zhao Z, Xie D, Gao Z. Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B. Hepatol Int. 2010;4:615\u201320.","journal-title":"Hepatol Int"},{"key":"535_CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0016-5085(85)90566-9","volume":"89","author":"IS Sheen","year":"1985","unstructured":"Sheen IS, Liaw YF, Tai DI, Chu CM. Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis. Gastroenterology. 1985;89:732\u20135.","journal-title":"Gastroenterology"},{"key":"535_CR21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2893.2006.00799.x","volume":"14","author":"MF Yuen","year":"2007","unstructured":"Yuen MF, Wong DK, Zheng BJ, et al. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion. J Viral Hepat. 2007;14:269\u201375.","journal-title":"J Viral Hepat"},{"key":"535_CR22","doi-asserted-by":"crossref","unstructured":"Devarbhavi \u2026 Sarin SK; for APASL ACLF Working party. Acute-on-chronic Liver Failure secondary to drugs: causes, outcome and predictors of mortality. J Hepatol. 2016;64:S232.","DOI":"10.1016\/S0168-8278(16)00220-8"},{"key":"535_CR23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/jgh.12191","volume":"28","author":"H Garg","year":"2013","unstructured":"Garg H, Kumar A, Sharma BC, Sarin SK, et al. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients withacute-on-chronic liver failure. J Gastroenterol Hepatol. 2013;28:1361\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"535_CR24","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3748\/wjg.v20.i10.2542","volume":"20","author":"T Bruns","year":"2014","unstructured":"Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol. 2014;20(10):2542\u201354.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"535_CR25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"A Albillos","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. Hepatology. 2014;61(6):1385\u201396. This provides the insight into the immune dysfunction in cirrhosis, its progression and its correlation to disease severity. It provides a basic understanding of immune-mediated injury and liver failure.","journal-title":"Hepatology"},{"key":"535_CR26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00134-010-2099-7","volume":"37","author":"PA Berry","year":"2011","unstructured":"Berry PA, Antoniades CG, Hussain MJ, Davies ET, et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive Care Med. 2011;37:453\u201360.","journal-title":"Intensive Care Med"},{"issue":"4","key":"535_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/liv.12415","volume":"34","author":"A Khanam","year":"2014","unstructured":"Khanam A, Trehanpati N, Sharma BC, Sarin SK. Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int. 2014;34(4):505\u201313. This original study in patients with ACLF as per the APASL definition nicely shows the mechanism for tissue injury in ACLF and the role of GCSF in modulating the same.","journal-title":"Liver Int"},{"key":"535_CR28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2011.02.022","volume":"55","author":"HD Nischalke","year":"2011","unstructured":"Nischalke HD, Berger C, Aldenhoff K, Gr\u00fcnhage F, et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol. 2011;55:1010\u20136.","journal-title":"J Hepatol"},{"issue":"2","key":"535_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molcel.2014.03.030","volume":"54","author":"R Chovatiya","year":"2014","unstructured":"Chovatiya R, Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol Cell. 2014;54(2):281\u20138. doi: 10.1016\/j.molcel.2014.03.030 . This paper describes the sequence of events, i.e. stress, host response and mechanism of inflammation leading to tissue injury, predisposition to infection and organ failure.","journal-title":"Mol Cell"},{"issue":"3","key":"535_CR30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","volume":"62","author":"J Michelena","year":"2015","unstructured":"Michelena J, Altamirano J, Abraldes JG, et al. Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology. 2015;62(3):762\u201372.","journal-title":"Hepatology"},{"key":"535_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","volume":"142","author":"V Garg","year":"2012","unstructured":"Garg V, Garg H, Khan A, Sarin SK, et al. Granulocyte-colony stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505\u201312. This study supports the concept of impaired regeneration in ACLF and the role of GCSF for augmented liver regeneration due to bone marrow.","journal-title":"Gastroenterology"},{"key":"535_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jhep.2009.06.013","volume":"51","author":"R Malik","year":"2009","unstructured":"Malik R, Mookerjee R, Jalan R. Infection and inflammation in liver failure: two sides of the same coin. J Hepatol. 2009;51:426\u20139.","journal-title":"J Hepatol"},{"key":"535_CR33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000232940","volume":"28","author":"Q Liu","year":"2009","unstructured":"Liu Q. Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif. 2009;28:331\u201341.","journal-title":"Blood Purif"},{"issue":"1","key":"535_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","volume":"59","author":"J Wan","year":"2014","unstructured":"Wan J, Benkdane M, Lotersztajn S, Pavoine C. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59(1):130\u201342. doi: 10.1002\/hep.26607 .","journal-title":"Hepatology"},{"key":"535_CR35","doi-asserted-by":"crossref","first-page":"17892","DOI":"10.1074\/jbc.M112351200","volume":"277","author":"F Desmots","year":"2002","unstructured":"Desmots F, Rissel M, Guillouzo A, Loyer P, et al. Pro-inflammatory cytokines tumor necrosis factor and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes. J Biol Chem. 2002;277:17892\u2013900.","journal-title":"J Biol Chem"},{"key":"535_CR36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","volume":"42","author":"HE Wasmuth","year":"2005","unstructured":"Wasmuth HE, Kunz D, Matern S, Lammert F, et al. Patients with acute-on-chronic liver failure display \u2018sepsis-like\u2019 immune paralysis. J Hepatol. 2005;42:195\u2013201. This article shows the immunological spectrum in ACLF and the resemblance of ACLF to a state of sepsis like immunoparalysis.","journal-title":"J Hepatol"},{"key":"535_CR37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.510270222","volume":"27","author":"DC Rockey","year":"1998","unstructured":"Rockey DC, Fouassier L, Rey C, Housset C, et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine eff ects on stellate cells. Hepatology. 1998;27:472\u201380.","journal-title":"Hepatology"},{"key":"535_CR38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.2010.60","volume":"90","author":"CJ Steib","year":"2010","unstructured":"Steib CJ, Hartmann AC, Bilzer M, Gerbes AL, et al. Intraperitoneal LPS amplifi es portal hypertension in rat liver fibrosis. Lab Investig. 2010;90:1024\u201332.","journal-title":"Lab Investig"},{"key":"535_CR39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","volume":"46","author":"RP Mookerjee","year":"2007","unstructured":"Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology. 2007;46:831\u201340.","journal-title":"Hepatology"},{"issue":"1","key":"535_CR40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2249.2006.03259.x","volume":"147","author":"T Xing","year":"2007","unstructured":"Xing T, Li L, Cao H, Huang J. Altered immune function of monocytes in different stages of patients with acute-on-chronic liver failure. Clin Exp Immunol. 2007;147(1):184\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"535_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","volume":"148","author":"C Bernsmeier","year":"2015","unstructured":"Bernsmeier C, Pop OT, Wendon J, Antoniades CG, et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology. 2015;148(3):603\u2013615.e14. doi: 10.1053\/j.gastro.2014.11.045 .","journal-title":"Gastroenterology"},{"issue":"9","key":"535_CR42","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1007\/s00134-013-3006-9","volume":"39","author":"C Guignant","year":"2013","unstructured":"Guignant C, Venet F, Planel S, et al. Increased MerTK expression in circulating innate immune cells of patients with septic shock. Intensive Care Med. 2013;39(9):1556\u201364. doi: 10.1007\/s00134-013-3006-9 .","journal-title":"Intensive Care Med"},{"key":"535_CR43","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/hep.23918","volume":"52","author":"P Bellot","year":"2010","unstructured":"Bellot P, Garcia-Pagan JC, Abraldes JG, Navasa M, Perez-Mateo M, Such J, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology. 2010;52:2044\u201352.","journal-title":"Hepatology"},{"key":"535_CR44","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","volume":"2","author":"V Arroyo","year":"2016","unstructured":"Arroyo V, Moreau R, Kamath PS, Jalan R, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers. 2016;2:16041.","journal-title":"Nat Rev Dis Primers"},{"key":"535_CR45","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","volume":"46","author":"D Thabut","year":"2007","unstructured":"Thabut D, Massard J, Moreau R, et al. Model for end-stage liver disease score and systemic inflammatory response Are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46:1872\u201382.","journal-title":"Hepatology"},{"issue":"3","key":"535_CR46","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s10620-015-3921-4","volume":"61","author":"R Maiwall","year":"2016","unstructured":"Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61(3):920\u20139.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"535_CR47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jgh.12778","volume":"30","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Duseja A, Gupta T, Dhiman RK, Chawla Y. Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol. 2015;30(3):575\u201381. This highlights that the number of organ failures is a simple and easy prognostication rather than complex scores in western ACLF patients.","journal-title":"J Gastroenterol Hepatol"},{"key":"535_CR48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12072-009-9148-8","volume":"3","author":"CA Chan","year":"2009","unstructured":"Chan CA, Fan ST, Lo CM, Liu CL, Chan SC, Ng KK, et al. Liver transplantation for acute-on-chronic liver failure. Hepatol Int. 2009;3:571\u201381.","journal-title":"Hepatol Int"},{"key":"535_CR49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u201360.","journal-title":"Gut"},{"key":"535_CR50","doi-asserted-by":"publisher","unstructured":"Yeoman AD, O\u2019Grady JG, Heneghan MA. Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome. J Hepatol. 2014. 10.1016\/j.jhep.2014.05.021","DOI":"10.1016\/j.jhep.2014.05.021"},{"key":"535_CR51","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","volume":"53","author":"AD Yeoman","year":"2011","unstructured":"Yeoman AD, Westbrook RH, Portmann C, O\u2019Grady OJ, Harrison PM, Heneghan MA. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology. 2011;53:926\u201334.","journal-title":"Hepatology"},{"issue":"2","key":"535_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00428-011-1115-9","volume":"459","author":"A Rastogi","year":"2011","unstructured":"Rastogi A, Kumar A, Sakhuja P, Bihari C, Gondal R, Sarin SK, et al. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Arch. 2011;459(2):121\u20137. The histology in ACLF as a prognostic marker has been highlighted in this article in patients of ACLF as per the APASL definition.","journal-title":"Virchows Arch"},{"issue":"5","key":"535_CR53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano J, Miquel R, Abraldes JG, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146(5):1231\u20139.e1-6.","journal-title":"Gastroenterology"},{"key":"535_CR54","first-page":"23","volume":"6","author":"J Krenitsky","year":"2003","unstructured":"Krenitsky J. Nutrition for patients with hepatic failure. Pract Gastroenterol. 2003;6:23\u201342.","journal-title":"Pract Gastroenterol"},{"key":"535_CR55","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ejcn.2013.163","volume":"67","author":"W Hou","year":"2013","unstructured":"Hou W, Li J, Wang JH, Meng QH. Carbohydrate-predominant LES is associated with increases in fasting carbohydrate oxidation, REE and reductions in fat oxidation in adults with ACLF. Therapeutic strategies utilizing LES may promote improved nutritional status in adults with ACLF. Eur J Clin Nutr. 2013;67:1251\u20136.","journal-title":"Eur J Clin Nutr"},{"key":"535_CR56","unstructured":"Maiwall R, Kumar S, Vashishtha C, Kumar M, Garg H, Nayak SL et al. Acute kidney injury (AKI) in patients with Acute-on-chronic Liver failure (ACLF) is different from patients with cirrhosis Hepatology. 58(4 (Suppl)):36A\u201391A."},{"key":"535_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12895","author":"A Jindal","year":"2015","unstructured":"Jindal A, Bhadoria AS, Maiwall R, Sarin SK. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure. Liver Int. 2015. doi: 10.1111\/liv.12895 .","journal-title":"Liver Int"},{"key":"535_CR58","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.transproceed.2013.02.127","volume":"45","author":"T Xing","year":"2013","unstructured":"Xing T, Zhong L, Chen D, et al. Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction. Transplant Proc. 2013;45:2307\u201313.","journal-title":"Transplant Proc"},{"key":"535_CR59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.24109","volume":"53","author":"H Garg","year":"2011","unstructured":"Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011;53:774\u201380. An excellent study that describes the role of disease-specific therapy, i.e. Nucs in HBV ACLF as a treatment, and the time frame for making a decision on definitive therapy.","journal-title":"Hepatology"},{"key":"535_CR60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","volume":"137","author":"A Louvet","year":"2009","unstructured":"Louvet A, Wartel F, Castel H, Mathurin P. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology. 2009;137:541\u20138.","journal-title":"Gastroenterology"},{"key":"535_CR61","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/hep.24159","volume":"53","author":"AJ Mambro","year":"2011","unstructured":"Mambro AJ et al. In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis. Hepatology. 2011;53:1316\u201322.","journal-title":"Hepatology"},{"key":"535_CR62","doi-asserted-by":"publisher","unstructured":"Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. advance online publication 17 March 2015. doi: 10.1038\/.nrgastro.2015.35","DOI":"10.1038\/.nrgastro.2015.35"},{"key":"535_CR63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/lt.23678","volume":"19","author":"A Finkenstedt","year":"2013","unstructured":"Finkenstedt A, Nachbaur K, Graziadei W, Vogel W. Acute-on-chronic liver failure: excellent outcomes after liver transplantation but high mortality on the wait list. Liver Transpl. 2013;19:879\u201386. This highlights the role of liver transplants in patients of ACLF and the high mortality in the absence of LT.","journal-title":"Liver Transpl"},{"key":"535_CR64","first-page":"6e","volume":"93","author":"BW Duan","year":"2013","unstructured":"Duan BW, Lu SC, Duan ZP, Li N. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases. J Surg Res. 2013;93:6e\u2013943.","journal-title":"J Surg Res"},{"issue":"9","key":"535_CR65","doi-asserted-by":"publisher","first-page":"e72893","DOI":"10.1371\/journal.pone.0072893","volume":"8","author":"K-H Lin","year":"2013","unstructured":"Lin K-H, Liu J-W, Chen C-L, Wang S-H, Lin C-C, Liu Y-W, et al. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure Who received living-donor liver transplantation. PLoS ONE. 2013;8(9):e72893. doi: 10.1371\/journal.pone.0072893 .","journal-title":"PLoS ONE"},{"key":"535_CR66","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/01.TP.0000087341.88471.E5","volume":"76","author":"CL Liu","year":"2003","unstructured":"Liu CL, Fan ST, Lo CM, et al. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation. 2003;76:1174\u20139.","journal-title":"Transplantation"},{"issue":"1","key":"535_CR67","doi-asserted-by":"publisher","first-page":"e30322","DOI":"10.1371\/journal.pone.0030322","volume":"7","author":"Q Ling","year":"2012","unstructured":"Ling Q, Xu X, Wei Q, Liu X, Guo H, et al. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure. PLoS ONE. 2012;7(1):e30322. doi: 10.1371\/journal.pone.0030322 .","journal-title":"PLoS ONE"},{"issue":"952\u2013957","key":"535_CR68","first-page":"196","volume":"92","author":"R Bahirwani","year":"2011","unstructured":"Bahirwani R, Shaked O, Bewtra M, Reddy RK. Acute\u2010on\u2010chronic liver failure before liver transplantation: impact on posttransplant outcomes. Transplantation. 2011;92(952\u2013957):196.","journal-title":"Transplantation"},{"key":"535_CR69","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.transproceed.2007.02.070","volume":"39","author":"ZX Wang","year":"2007","unstructured":"Wang ZX et al. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute\u2010on\u2010chronic hepatitis B liver failure. Transplant Proc. 2007;39:1501\u20134.","journal-title":"Transplant Proc"},{"key":"535_CR70","doi-asserted-by":"crossref","unstructured":"Pamecha V, Kumar S, Bharathy KG. Liver transplantation in acute-on-chronic liver failure: challenges and an algorithm for patient selection and management. Hepatol Int. 2015.","DOI":"10.1007\/s12072-015-9646-9"},{"key":"535_CR71","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","volume":"365","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, Moreno C, Samuel D, Pruvot FR, Vall\u00e9e JC. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365:1790\u2013800.","journal-title":"N Engl J Med"},{"issue":"1","key":"535_CR72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","volume":"62","author":"T Gustot","year":"2015","unstructured":"Gustot T, Fernandez J, Garcia E, for CANONIC Study Investigators of the EASL-CLIF Consortium, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243\u201352. This landmark study defined the natural history, outcome of transplants, and when and in whom to consider the futility of care in patients of ACLF.","journal-title":"Hepatology"},{"issue":"2 Supplement","key":"535_CR73","first-page":"505","volume":"8","author":"R Maiwall","year":"2014","unstructured":"Maiwall R, Maras JS, Nayak S, Sarin SK. Liver dialysis in acute-on-chronic liver failure: current and future 3 perspectives. International. 2014;8(2 Supplement):505\u201313. This review article describes in detail the mechanism, role and when to plan in which group of patients about bridging therapy.","journal-title":"International"},{"key":"535_CR74","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","volume":"142","author":"A Kribben","year":"2012","unstructured":"Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:782\u20139.e3.","journal-title":"Gastroenterology"},{"key":"535_CR75","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","volume":"57","author":"R Banares","year":"2013","unstructured":"Banares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57:1153\u201362.","journal-title":"Hepatology"},{"issue":"1","key":"535_CR76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MAT.0b013e31823fd077","volume":"58","author":"A Vaid","year":"2012","unstructured":"Vaid A, Chweich H, Balk EM, Jaber BL. Molecular adsorbent recirculating system as artIficial support therapy for liver failure: a meta-analysis. ASAIO J. 2012;58(1):51\u20139.","journal-title":"ASAIO J"},{"key":"535_CR77","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1525-1594.1994.tb02216.x","volume":"18","author":"SR Ash","year":"1994","unstructured":"Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs. 1994;18:355\u201362.","journal-title":"Artif Organs"},{"key":"535_CR78","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.20236","volume":"10","author":"S Sen","year":"2004","unstructured":"Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl. 2004;10:1109\u201319.","journal-title":"Liver Transpl"},{"key":"535_CR79","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc4985","volume":"10","author":"W Laleman","year":"2006","unstructured":"Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108.","journal-title":"Crit Care"},{"issue":"5","key":"535_CR80","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/bjs.7418","volume":"98","author":"BM Stutchfield","year":"2011","unstructured":"Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg. 2011;98(5):623\u201331. doi: 10.1002\/bjs.7418 .","journal-title":"Br J Surg"},{"issue":"4","key":"535_CR81","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/etm.2013.1241","volume":"6","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Li X, Li Z, Ma X. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression. Exp Ther Med. 2013;6(4):929\u201336.","journal-title":"Exp Ther Med"},{"key":"535_CR82","doi-asserted-by":"crossref","unstructured":"Demetriou AA, Brown RS, Busuttil RW et al. Prospective, randomised multicen-ter controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2002;239:660\u201370. Liver support systems. Ann Surg 2004;240:216\u2013230.","DOI":"10.1097\/01.sla.0000132986.75257.19"},{"issue":"1","key":"535_CR83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2013.01.018","volume":"59","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Wang FS. Stem cell therapies for liver failure and cirrhosis. J Hepatol. 2013;59(1):183\u20135.","journal-title":"J Hepatol"},{"issue":"5","key":"535_CR84","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrgastro.2010.44","volume":"7","author":"A Dhawan","year":"2010","unstructured":"Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol. 2010;7(5):288\u201398. doi: 10.1038\/nrgastro.2010.44 .","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"535_CR85","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.transproceed.2013.10.042","volume":"46","author":"F Wang","year":"2014","unstructured":"Wang F, Zhou L, Ma X, Ma W, Wang C, Lu Y, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study. Transplant Proc. 2014;46(1):192\u20138.","journal-title":"Transplant Proc"},{"issue":"1S","key":"535_CR86","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/j.jhep.2015.02.040","volume":"62","author":"SJ Forbes","year":"2015","unstructured":"Forbes SJ, Gupta S, Dhawan A. Cell therapy for liver disease: from liver transplantation to cell factory. J Hepatol. 2015;62(1S):S157\u201369.","journal-title":"J Hepatol"},{"issue":"1","key":"535_CR87","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","volume":"8","author":"L Spahr","year":"2013","unstructured":"Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013;8(1):e53719.","journal-title":"PLoS One"},{"issue":"123","key":"535_CR88","first-page":"406","volume":"60","author":"X Liao","year":"2013","unstructured":"Liao X, Ancheng JY, Zhou QJ, Liao C. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis. Hepatogastroenterology. 2013;60(123):406\u20139.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"535_CR89","first-page":"12","volume":"14","author":"S Nikeghbalian","year":"2011","unstructured":"Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SM, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med. 2011;14(1):12\u20137.","journal-title":"Arch Iran Med"},{"key":"535_CR90","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","volume":"109","author":"V Singh","year":"2014","unstructured":"Singh V, Sharma AK, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis : a randomized pilot study. Am J Gastroenterol. 2014;109:1417\u201323.","journal-title":"Am J Gastroenterol"},{"key":"535_CR91","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","volume":"39","author":"C Campli Di","year":"2007","unstructured":"Di Campli C, Zocco MA, Saulnier N, et al. Safety and efficacy profile of G-CSF therapy in patients with acute-on-chronic liver failure. Dig Liver Dis. 2007;39:1071\u20136.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"535_CR92","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","volume":"19","author":"XZ Duan","year":"2013","unstructured":"Duan XZ, Liu FF, Tong JJ, Hu JH. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute on- chronic liver failure. World J Gastroenterol. 2013;19(7):1104\u201310.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"535_CR93","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","volume":"148","author":"CK Kedarisetty","year":"2015","unstructured":"Kedarisetty CK, Anand L, Bhatia V, Sarin SK. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology. 2015;148(7):1362\u20131370.e7.","journal-title":"Gastroenterology"},{"issue":"1","key":"535_CR94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.24673","volume":"55","author":"F Meng","year":"2012","unstructured":"Meng F, Francis H, Glaser S, Alpini G. Role of stem cell factor and granulocyte colony-stimulating factor in remodeling during liver regeneration. Hepatology. 2012;55(1):209\u201321.","journal-title":"Hepatology"},{"key":"535_CR95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOH.0b013e328338b7d5","volume":"17","author":"I Pusic","year":"2010","unstructured":"Pusic I, Di Persio JF. Update on clinical experience with amd3100, an sdf-1\/cxcl12-cxcr4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol. 2010;17:319\u201326.","journal-title":"Curr Opin Hematol"},{"key":"535_CR96","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cct.2008.04.006","volume":"29","author":"YL Cui","year":"2008","unstructured":"Cui YL, Meng MB, Tang H, et al. Recombinant human hepatocyte growth factor for liver failure. Contemp Clin Trials. 2008;29:696\u2013704.","journal-title":"Contemp Clin Trials"},{"key":"535_CR97","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/lt.22100","volume":"16","author":"F Greif","year":"2010","unstructured":"Greif F, Ben-Ari Z, Ravid A, Hochhauser E. Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats. Liver Transpl. 2010;16:631\u20138.","journal-title":"Liver Transpl"},{"key":"535_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27708","author":"AC Piscaglia","year":"2015","unstructured":"Piscaglia AC, Arena V, Passalacqua S, Gasbarrini A. A case of granulocyte-colony stimulating factor\/plasmapheresis-induced activation of granulocyte-colony stimulating factor-positive hepatic progenitors in acute-on-chronic liver failure. Hepatology. 2015. doi: 10.1002\/hep.27708 .","journal-title":"Hepatology"},{"issue":"4","key":"535_CR99","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","volume":"11","author":"JP Hwang","year":"2014","unstructured":"Hwang JP, Lok AS. Management of patients with hepatitis B who require immunosuppressive therapy.Nat Rev. Gastroenterol Hepatol. 2014;11(4):209\u201319. doi: 10.1038\/nrgastro.2013.216 .","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"535_CR100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v7.i3.425","volume":"7","author":"H Fukui","year":"2015","unstructured":"Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol. 2015;7(3):425\u201342.","journal-title":"World J Hepatol"},{"key":"535_CR101","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/gut.2008.163675","volume":"58","author":"S Verma","year":"2009","unstructured":"Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut. 2009;58:1555\u201364. doi: 10.1136\/gut.2008.163675 .","journal-title":"Gut"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-016-0535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-016-0535-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-016-0535-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T09:45:20Z","timestamp":1657446320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-016-0535-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1007\/s11894-016-0535-8","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]},"article-number":"61"}}